Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression
- PMID: 18047805
- DOI: 10.5483/bmbrep.2007.40.6.1069
Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression
Abstract
Cancer cells, characterized by local invasion and distant metastasis, are very much dependent on the extracellular matrix. The expression of matrix metalloproteinases (MMPs) has been implicated in the invasion and metastasis of cancer cells. In this study, we reported the effects of disulfiram, a clinically used anti-alcoholism drug, on tumor invasion suppression, as well as its effects on the activity of MMP-2 and MMP-9 in human osteosarcoma cells (U2OS). Disulfiram has been used for alcohol aversion therapy. However, recent reports have shown that disulfiram may have potential in the treatment of human cancers. Herewith, we showed that the anti-tumor effects of disulfiram, in an invasion assay using U2OS cells and that disulfiram has a type IV collagenase inhibitory activity that inhibits expression of genes and proteins responsible for both cell and non-cell mediated invasion on pathways. In conclusion, disulfiram inhibited expression of MMP-2 and MMP-9 and it regulated the invasion of human osteosarcoma cells. These observations raise the possibility of disulfiram being used clinical for the inhibition of cancer invasion.
Similar articles
-
Risedronate inhibits human osteosarcoma cell invasion.J Exp Clin Cancer Res. 2009 Jul 22;28(1):105. doi: 10.1186/1756-9966-28-105. J Exp Clin Cancer Res. 2009. PMID: 19624845 Free PMC article.
-
Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.Environ Toxicol. 2014 Jan;29(1):21-9. doi: 10.1002/tox.20769. Epub 2011 Sep 16. Environ Toxicol. 2014. PMID: 21922632
-
Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram.Mol Pharmacol. 2003 Nov;64(5):1076-84. doi: 10.1124/mol.64.5.1076. Mol Pharmacol. 2003. PMID: 14573756
-
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.J Nat Prod. 2022 Oct 28;85(10):2424-2432. doi: 10.1021/acs.jnatprod.2c00626. Epub 2022 Sep 19. J Nat Prod. 2022. PMID: 36122348 Review.
-
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review.Clin Sarcoma Res. 2020 Apr 30;10:7. doi: 10.1186/s13569-020-00128-6. eCollection 2020. Clin Sarcoma Res. 2020. PMID: 32377334 Free PMC article. Review.
Cited by
-
A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas.Clin Sarcoma Res. 2018 Nov 5;8:21. doi: 10.1186/s13569-018-0107-9. eCollection 2018. Clin Sarcoma Res. 2018. PMID: 30410720 Free PMC article.
-
Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma.Mol Cells. 2015 May;38(5):432-40. doi: 10.14348/molcells.2015.2327. Epub 2015 Feb 17. Mol Cells. 2015. Retraction in: Mol Cells. 2020 Oct 31;43(10):898. doi: 10.14348/molcells.2020.3327 PMID: 25728753 Free PMC article. Retracted.
-
MicroRNA-1253 Suppresses Cell Proliferation Migration and Invasion of Osteosarcoma by Targeting MMP9.Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821995278. doi: 10.1177/1533033821995278. Technol Cancer Res Treat. 2021. PMID: 34036868 Free PMC article.
-
Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells.Sarcoma. 2013;2013:480713. doi: 10.1155/2013/480713. Epub 2013 Feb 14. Sarcoma. 2013. PMID: 23476113 Free PMC article.
-
High expression of osteoglycin decreases gelatinase activity of murine hepatocarcinoma Hca-F cells.World J Gastroenterol. 2009 Dec 28;15(48):6117-22. doi: 10.3748/wjg.15.6117. World J Gastroenterol. 2009. PMID: 20027687 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous